NCT05046431View on ClinicalTrials.gov

Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

704

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

October 6, 2023

Study Completion Date

October 6, 2023

Conditions
Psoriatic Arthritis
Interventions
DRUG

BAT2506

50mg/0.5mL

DRUG

EU Simponi

50mg/0.5mL

Trial Locations (1)

Unknown

West China Hospital Sichuan University, Chengdu

Sponsors
All Listed Sponsors
lead

Bio-Thera Solutions

INDUSTRY